The diagnosis of RA involves assessing the type and number of affected joints, serological analysis for rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) concentration, acute phase reactants, and symptom duration, all based on established classification standards. This evidence concerns the gene PRTN3 and rheumatoid arthritis.